Company Overview of C3J Therapeutics, Inc.
C3J Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of therapeutics aimed at reengineering the human microbiome. The company improves human health through the development and commercialization of targeted or pathogen-specific antimicrobials (STAMPs) that treat and prevent human diseases caused by microbial dysbiosis. It offers STAMP platform technology for targeted antimicrobial therapy and correcting microbial dysbiosis. C3J Therapeutics, Inc. was formerly known as C3 Jian, Inc. and changed its name to C3J Therapeutics, Inc. in November 2016. The company was incorporated in 2005 and is headquartered in Marina del Rey, California.
4503 Glencoe Avenue
Marina del Rey, CA 90292
Founded in 2005
Key Executives for C3J Therapeutics, Inc.
C3J Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
December 7, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact C3J Therapeutics, Inc., please visit www.c3jtherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.